Examining memory in children with oral language development disorders
Coding and Memorisation of Phonologic Information Among Preschool and School Children With Oral Language Developement Disorder.
This study is testing how well children with language development disorders remember things compared to kids with normal language skills to see if improvements in their language help their memory.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 264 (estimated) |
| Ages | 45 Months to 95 Months |
| Sex | All |
| Sponsor | Lille Catholic University Academic / other |
| Locations | 1 site (Lille, Nord-Pas-de-Calais) |
| Trial ID | NCT02609542 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the memorization capabilities of children diagnosed with Specific Troubles of Oral Language (STOL) compared to those with normal language development. It focuses on children aged 45 to 95 months, assessing their verbal memory performance through eye tracking techniques. The hypothesis suggests that children whose STOL condition improves between ages 4 and 7 will perform better in verbal memorization tasks than those with persistent STOL. The study aims to enhance understanding of language development disorders and their impact on memory.
Who should consider this trial
Good fit: Ideal candidates include children aged 3 years 9 months to 7 years 11 months diagnosed with STOL and those with normal language development.
Not a fit: Patients with pervasive developmental disorders or those whose mother language is not French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for supporting children with language development disorders.
How similar studies have performed: While similar studies have explored language development, this specific approach using eye tracking in STOL patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria for STOL patients: * Child aged between 45 and 95 months at inclusion * A score \> or equal to 5 percentile on the non verbal intelligence test (PM47) * Patient diagnosed with STOL by the neuropediatric medical team * Coverage of the social insurance * Consent form signed by the parents or the legal representative of the child * Normal or corrected sight * Normal hearing Inclusion Criteria for control patients: * Child aged between 45 and 95 months on the day of inclusion * A score \> or equal to 5 percentile on the non verbal intelligence test (PM47) * Child who did not receive any speech therapy * Coverage of the social insurance * Consent form signed by the parents or the legal representative of the child * Normal or corrected sight * Normal hearing Exclusion Criteria for STOL patients: * Mother language other than French * Score \< to 5 percentile on the non verbal intelligence test (PM47) * Child with pervasive developmental disorder Exclusion Criteria for control patients: * Mother language other than French * Score \< to 5 percentile on the non verbal intelligence test (PM47) * Child who received speech therapy
Where this trial is running
Lille, Nord-Pas-de-Calais
- Hôpital St Vincent-de-Paul (GHICL) — Lille, Nord-Pas-de-Calais, France (Recruiting)
Study contacts
- Principal investigator: Delphine Fleurion, Psychologist — Groupement des Hôpitaux de l'Institut Catholique de Lille
- Study coordinator: Amélie Lansiaux, MD, PhD
- Email: lansiaux.amelie@ghicl.net
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.